You watched
Catalog
Client
Currency:
+380 66 708 47 52
Our location:
Ternopil city
Phones:
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
1
Wishlist
0
Compare
0
Contacts

Blimol solution for infusion 10 mg/ml bottle 100 ml No. 1

SKU: an-1049908
0
All about product
Description
Specification
Reviews 0
Questions0
new
Blimol solution for infusion 10 mg/ml bottle 100 ml No. 1
Blimol solution for infusion 10 mg/ml bottle 100 ml No. 1
Blimol solution for infusion 10 mg/ml bottle 100 ml No. 1
Blimol solution for infusion 10 mg/ml bottle 100 ml No. 1
In Stock
368.50 грн.
Buy this product in 1 click:
Active ingredient:Paracetamol
Adults:Can
ATC code:N NERVOUS SYSTEM AGENTS; N02 ANALGETICS; N02B OTHER ANALGETICS AND ANTIPYRETICS; N02B E Anilides; N02B E01 Paracetamol
Country of manufacture:India
Diabetics:Can
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Blimol solution for infusion 10 mg/ml bottle 100 ml No. 1
368.50 грн.
Description

Blimol solution for infusion is indicated for:

adults:

for short-term treatment of moderate pain syndrome, especially in the postoperative period. for short-term treatment of hyperthermic reactions, when only intravenous administration of the drug is necessary.

Children: for symptomatic treatment of pain and hyperthermia in postoperative patients.

Composition

active ingredient: paracetamol;

1 ml of solution contains paracetamol - 10 mg;

Excipients: propylene glycol; citric acid monohydrate, sodium metabisulfite (E 223), sodium phosphate dihydrate; sodium chloride, water for injections.

Contraindication

hypersensitivity to paracetamol and other components of the drug; severe hepatocellular insufficiency; severe liver and/or kidney dysfunction; congenital hyperbilirubinemia; glucose-6-phosphate dehydrogenase deficiency; alcoholism; blood diseases; Gilbert's syndrome; severe anemia; leukopenia.

Method of application

Blimol is used for rapid relief of pain and/or hyperthermia when only intravenous administration of the drug is necessary.

The duration of the infusion should be 15 minutes.

In patients with renal insufficiency (creatinine clearance <30 ml/min), the interval between doses should be increased to 6 hours. The duration of treatment should not exceed 48 hours.

For adult patients with hepatocellular insufficiency, chronic alcoholism, chronic nutritional disorders (low hepatic glutathione reserves), dehydration, the maximum daily dose should not exceed 3 g.

Application features

Pregnant women

Not recommended.

Children

Do not use in children under 1 year of age and weighing less than 10 kg.

Use in children aged 1 year and over with a body weight of more than 10 kg only for symptomatic treatment of pain and hyperthermia in postoperative patients.

Drivers

No effect.

Overdose

The risk of toxic effects of the drug increases in the elderly, children, patients with liver failure, in cases of chronic alcoholism, in the presence of alimentary dystrophy and in people with reduced enzymatic activity. In these cases, overdose can be fatal.

Symptoms appear within the first 24 hours and are manifested by nausea, vomiting, anorexia, pallor, and abdominal pain.

Overdose in adults can occur with a single administration of 7.5 g or more, in children - 140 mg / kg of body weight. In this case, liver cytolysis, liver failure, metabolic acidosis, encephalopathy develop, which can lead to coma and death of the patient. Within 12-48 hours, the level of hepatic transaminases (AST, ALT), lactate dehydrogenase, bilirubin increases and the level of prothrombin decreases. Clinical symptoms of liver damage appear after two days and reach a maximum after 4-6 days.

Treatment: immediate hospitalization of the patient. Administration of SH-group donors and precursors of glutathione-methionine synthesis after 8-9 hours. After overdose and N-acetylcysteine - after 12.00. The need for additional therapeutic measures (further administration of methionine, intravenous administration of N-acetylcysteine) is determined depending on the concentration of paracetamol in the blood, as well as the time elapsed after its administration.

Side effects

Blood and lymphatic system disorders: thrombocytopenia, leukopenia, neutropenia, agranulocytosis, anemia, sulfhemoglobinemia and methemoglobinemia (cyanosis, shortness of breath, heart pain), hemolytic anemia, bruising or bleeding. Immune system disorders: angioedema. Gastrointestinal tract: nausea, epigastric pain. Skin and subcutaneous tissue disorders: erythema multiforme (including Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell's syndrome). Cardiac disorders: shortness of breath, hypotension, tachycardia. Metabolism disorders: hypoglycemia, up to hypoglycemic coma. General: malaise, weakness, pain and burning at the injection site, skin redness, hypersensitivity reactions, anaphylactic shock.

Interaction

Inducers of microsomal oxidation in the liver (phenytoin, ethanol, barbiturates, rifampicin, phenylbutazone, tricyclic antidepressants) can contribute to the development of severe intoxications even with a small overdose.

Paracetamol reduces the effectiveness of diuretics.

Paracetamol should not be used simultaneously with alcohol.

Storage conditions

Store in a place protected from light at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life - 2 years.

Specifications
Characteristics
Active ingredient
Paracetamol
Adults
Can
ATC code
N NERVOUS SYSTEM AGENTS; N02 ANALGETICS; N02B OTHER ANALGETICS AND ANTIPYRETICS; N02B E Anilides; N02B E01 Paracetamol
Country of manufacture
India
Diabetics
Can
Dosage
10 mg/ml
Drivers
Can
For allergies
With caution
For children
From the 1st year
Form
Infusions
Method of application
Injections
Nursing
It is impossible.
Pregnant
It is impossible.
Producer
Unique Pharmaceutical Laboratories
Quantity per package
100 ml
Trade name
Blimol
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
Ceftazidime powder for solution for injection 1 g vial No. 1
In stock
0
314.35 грн.
368.50 грн.